Explore how autologous bone marrow transplants offer hope for patients, including Jehovah’s Witnesses, on World Cancer Day.

ACCESS trial results at the 2026 Tandem Meetings reinforce mismatched unrelated donors as safe, effective and well-tolerated ...

Two-year follow-up data demonstrate sustained benefit, including improvements in pain, fatigue and bone health, following single low dose of avigbagene parvec (FLT201) ...

However, with these recommendations, patients with advanced blood cancers use hospice much less than patients with solid tumors. These advanced cancers include leukemia, lymphoma and multiple myeloma, ...

Neomorph begins human testing of a molecular glue therapy that selectively removes cancer-driving proteins, targeting clear cell renal cell carcinoma.

Comparative Study of Chemotherapy Tolerance and Immune Function Changes in Gynecological Malignancy Patients with HIV ...